Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO:1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO:1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides is described. An anti-inflammatory composition comprising the above mentioned peptides is described. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention provides a method for determining low mass ions for diagnosing colorectal cancer by using a MALDI-TOF mass spectrometer to biostatistically analyze low mass ions, which are extracted from a biological sample, and a method for providing information for diagnosing colorectal cancer using same. The present inventions can provide a diagnostic method, which requires low cost and a short time for analysis, can analyze large areas, and which can provide superior and credible discriminations.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, the peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides is described. An anti-inflammatory composition comprising the above mentioned peptides is described. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating a variety of different types of inflammatory diseases.

Abstract: A peptide with anti-inflammatory activity is described, wherein the peptide comprises at least one amino acid sequence among SEQ ID NO: 2 to SEQ ID NO: 179, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The peptides that have at least one amino acid sequence of SEQ ID NO: 2 to SEQ ID NO: 179 shows outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising those peptides can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A poorly soluble drug containing microsphere with improved bioavailability, an oral formulation comprising the same, and a method of preparing the same are provided, wherein the poorly soluble drug containing microsphere is a solid dispersion wherein the poorly soluble drug is dispersed in the water-soluble polymer carrier in a noncrystalline form by spray drying, thus increasing bioavailability of the poorly soluble drug.

Abstract: An emergency routing apparatus may include receiving a request for help from a portable device and processing the request to contact an appropriate emergency call center. The emergency call center may be determined based on location of the mobile device that is received with the request for help. If a connection can be established over a first communication link, the request for help may be transmitted to the emergency call center over the first communication link. If a connection cannot be established over the first communication link, another communication link may be used to transmit the request for help to the emergency call center. Transmitting the request for help over the other communication link may include dialing a phone number of the emergency call center and playing a message with the request for help over the other communication link.

Abstract: The present invention relates to a financial device and a control method and system thereof. The financial device may comprise: one or more selection portions; and a control unit configured to process any one of a plurality of financial processes, when any one of the one or more selection portions is input.

Abstract: A display device including a display panel including a chip mounting region and a driver mounted on the chip mounting region, the driver configured to provide signals to a display region of the display device to display an image on the display region. The display panel includes a first connection line, a second connection wire line, and a third connection wire line sequentially disposed in the chip mounting region; a first shorting bar, a second shorting bar, and a third shorting bar correspondingly connected to the first connection wire line, the second connection wire line, and the third connection wire line; and a bridge wire line configured to electrically connect at least one of the first, second, and third shorting bars and the second connection wire line. Neighboring connection wire lines of the first, second, and third connection wire lines are disposed in different layers.

Abstract: The present invention relates to diagnosis of ovarian cancer using lysophosphatidylcholine (16:0) and homocysteic acid, which are low-mass ions present in biological samples. The use of the present invention enables ovarian cancer to be diagnosed in a cost-effective, rapid and accurate manner. Thus, it is expected that the present invention will be effectively used to diagnose and treat ovarian cancer.

Abstract: Disclosed are a controlled release pharmaceutical composition, comprising a melt-extruded pellet including a water-insoluble ammonium methacrylate copolymer, a polyvinyl acetate, and an active ingredient; and a polymer coating layer including a water-insoluble ammonium methacrylate copolymer formed on the surface of the pellet, and an oral formulation including the pharmaceutical composition.

Abstract: Disclosed are dry granules comprising temozolomide and tartaric acid as a pH stabilizer, a pharmaceutical composition including the dry granules with improved stability and a method of preparing the same.

Abstract: The present invention relates to an automatic cooking pot notifying the completion of cooking. More specifically, provided is an automatic cooking pot which has a function of automatically notifying the optimal completion of a broth-based food, which retains a broth even when cooking is completed. Furthermore, if a user puts ingredients into the pot before the water boils, and selects a cooking menu wherein the same boiling time duration is set for the same menu regardless of the amount of food, the automatic cooking pot provided herewith notifies the user when the cooking is completed. In another embodiment, the user may adjust the boiling time duration to be set on a timer unit for the same food within a certain time range according to the amount of the food, on the basis of the variation in data in the boiling time durations depending on the amount of the food which have been measured through experiments beforehand.

Abstract: Embodiments of the present disclosure provide systems and methods for controlling a camera based on movement of a user detected by another camera. A system may include a first camera capturing images of a user, a display located in the vicinity of the first camera, the display displaying, in real time, video received from a second camera disparately located from the first camera. The system may include one or more processors coupled to the first camera, the second camera and the display, the processor(s) analyzing the images captured by the first camera to determine head and eye movement of the user, determining camera settings for the second camera based on the determined head and/or eye movement of the user, and transmitting the determined camera settings to the second camera.

Abstract: The present disclosure provides systems and methods for monitoring an area by an imaging system and detecting an incapacitated person in the monitored area. An incapacitated person monitoring apparatus may include a processing system configured to receive video data from at least one camera, the video data including a plurality of sequentially captured images. The processing system may be further configured to detect a body of a person in the images, and determine whether the detected body of the person in the images satisfies one or more first conditions identifying an incapacitated person. When the body of the person satisfied one or more first conditions, a notification may be transmitted to one or more notification locations.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises any one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161, the peptide has above 80% homology of amino acid sequence with above-mentioned sequences, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide that has at least one amino acid sequence of SEQ ID NO: 1 to SEQ ID NO: 161 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptides of this invention can be used as anti-inflammatory pharmaceutical compositions or as cosmetic compositions, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: The present invention relates to a peptide with anti-inflammatory activity, wherein the peptide comprises SEQ ID NO: 1, the peptide has above 80% homology of amino acid sequence with above-mentioned sequence, or the peptide is the fragment of the above-mentioned peptides. The present invention also relates to an inflammatory composition comprising the above mentioned peptides. According to the present invention, a peptide comprising a sequence of SEQ ID NO: 1 has outstanding efficacy in both suppressing inflammation and in prophylactic means. Therefore, the composition comprising the peptide of this invention can be used as anti-inflammatory pharmaceutical composition or as cosmetic composition, in turn, treating and preventing a variety of different types of inflammatory diseases.

Abstract: A display panel includes a gate driver connected to a gate line, where the gate driver includes a plurality of stages, where each of the stages includes at least one dual gate thin film transistor having a first control terminal and a second control terminal, and where each of the stages receives a clock signal, a first low voltage, a second low voltage, at least one transmission signal of previous stages, at least two transmission signals of subsequent stages and an output control signal from one of the stages to output a gate voltage including a gate-on voltage and a gate-off voltage.